DBVTF DBV Technologies S.A.
Price Chart
Executive Summary
DBV Technologies reported Q1 2026 financial results, showing a net loss of $47.6M, widening from $27.1M in Q1 2025, driven by increased R&D and SG&A spending as the company prepares for BLA submission and commercial launch. Cash and cash equivalents stood at $229M, providing runway into Q2 2027. The stock will move on BLA submission timing and FDA decisions, not on these pre-revenue financials.
Actionable Insight
Monitor for BLA submission announcement for children aged 4-7 in H1 2026 — this is the primary catalyst. The cash runway into Q2 2027 provides a long enough window for FDA review, but any delay in submission would be negative.
Key Facts
- Net loss of $47.6M for Q1 2026 vs $27.1M in Q1 2025
- Cash and cash equivalents of $229M as of March 31, 2026
- R&D expenses increased by $12M YoY to $33.4M
- SG&A expenses increased by $9M YoY to $10.5M
- Operating cash outflow of $49M vs $20M in Q1 2025
- BLA submission for children aged 4-7 anticipated in H1 2026
- BLA submission for toddlers aged 1-3 anticipated in H2 2026
Financial Impact
Net loss widened by $20.5M YoY; cash burn increased to $49M operating cash outflow
Risk Factors
- BLA submission delays or FDA rejection
- Cash burn rate accelerating faster than guided
- No revenue until potential approval and launch
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-197921 |
| Document: d132063d8k.htm | 0001193125-26-197921 |
| Document: 0001193125-26-197921-index-headers.html | 0001193125-26-197921 |
| Document: 0001193125-26-197921-index.html | 0001193125-26-197921 |
| Document: 0001193125-26-197921.txt | 0001193125-26-197921 |
| 8-K Data (Synthetic) | 0001193125-26-197921 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
8-K
| $4.26 awaiting T+20 | awaiting T+20 | — | $4.26 (+0.00%) |
|
Apr 30, 2026
6w ago
|
8-K
| $4.26 $4.26 | · 0.00% | ▼ −5.27% | $4.26 (+0.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access